Interleukin 24 as a novel potential cytokine immunotherapy for the treatment of Mycobacterium tuberculosis infection
Yunfeng Ma(Shenyang Pharmaceutical University), Xiao‐Lian Zhang(Wuhan University), Yinglan Zhao(Sichuan University), Haidan Chen(Wuhan University), Yingying Li(Shandong University of Traditional Chinese Medicine), Qilong Wang(Tianjin University of Traditional Chinese Medicine), Yubin Wang(Western University of Health Sciences)
Cited by 52
Related Papers
Targeting cellular metabolism to improve cancer therapeutics
|Cell Death and Disease|2013|1k
Tumor biomarkers for diagnosis, prognosis and targeted therapy
|Signal Transduction and Targeted Therapy|2024|600
Correction: Corrigendum: Differential developmental requirement and peripheral regulation for dermal Vγ4 and Vγ6T17 cells in health and inflammation
|Nature Communications|2016|536
The crystal structure of Cpf1 in complex with CRISPR RNA
|Nature|2016|421
IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients
|Advances in Clinical and Experimental Medicine|2017|248